CDC25B
M-phase inducer phosphatase 2
Protein Summary
Tyrosine protein phosphatase which functions as a dosage-dependent inducer of mitotic progression. Required for G2/M phases of the cell cycle progression and abscission during cytokinesis in a ECT2-dependent manner. Directly dephosphorylates CDK1 and stimulates its kinase activity. The three isoforms seem to have a different level of activity. CDC25B is a member of the CDC25 family of phosphatases. CDC25B activates the cyclin dependent kinase CDC2 by removing two phosphate groups and it is required for entry into mitosis. CDC25B shuttles between the nucleus and the cytoplasm due to nuclear localization and nuclear export signals. The protein is nuclear in the M and G1 phases of the cell cycle and moves to the cytoplasm during S and G2. CDC25B has oncogenic properties, although its role in tumor formation has not been determined. Multiple transcript variants for this gene exist. [provided by RefSeq, Jul 2008]
- ENST00000245960
- ENSP00000245960
- ENSG00000101224
- ENST00000340833
- ENSP00000339170
- ENST00000439880
- ENSP00000405972
- CDC25HU2
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
|---|---|---|---|
kinase | 1 | ||
hub protein | 0.98 | ||
biological term | 0.73 | ||
transcription factor | 0.73 | ||
biological process | 0.72 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 281.51 (req: < 5)
Gene RIFs: 75 (req: <= 3)
Antibodies: 866 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 281.51 (req: >= 5)
Gene RIFs: 75 (req: > 3)
Antibodies: 866 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 15
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligands: 63
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 0